September 24, 2025
Akira presents his progress on mechanistic interpretability of DNALMs in the I3H Informatics meeting. Akira did an amazing job explaining a complex topic with a lot of emerging concepts!
September 24, 2025
Miyako presents her chalk talk to the I3H faculty committee summarizing her rotation work and findings. Miyako gave an awesome presentation with strong scientific reasoning!
September 15, 2025
Boqi Wang joins us as a new computational scientist in the lab. Welcome Boqi!
Boqi will develop new computational pipelines towards more personalized genomics and multimodal data integration in autoimmunity.
September 10, 2025
Miyako practices her chalk talk with the rest of the IGG students. Everyone agreed she is totally ready!
September 1, 2025
Miyako Noguchi joins us for her IGG PhD thesis. Welcome Miyako!
Miyako will work on the role of transposable elements in shaping adaptive immune responses in the context of autoimmunity.
June 16, 2025
Akira Nair joins us for his GCB PhD thesis. He will be co-mentored by the Kim and Apostolidis labs - welcome Akira!
Akira will work on building models that extract clinically meaningful information from integrated datasets in autoimmunity.
April 24, 2025
The lab was awarded an Arthritis National Research Foundation grant to study the role of CD8 T cells in the development of rheum irAEs.
Sokratis was recognized as the Carl F. Ware, PhD Fellow - a named fellowship awarded in honor of Dr. Ware. A big thank you to ANRF for their support!
April 16, 2025
Felix presents his CD8 T cell work on irAEs during the Penn Colton retreat at the Franklin Institute. Great job Felix!
November 1, 2024
Eleni Bouziani joins the lab as a new post-doctoral fellow - welcome Eleni!
Eleni will work on understanding immune dysregulation in both primary and iatrogenic autoimmunity.
October 17, 2024
Our ONT MinION arrives in the lab! We are all excited to start analyzing some reeeaaally long transcripts.
September 3, 2024
Felix Li joins the lab as a research specialist A - welcome Felix!
Felix will work on the fundamental mechanisms that drive autoimmunity after cancer immunotherapy.
